- Article
Th2 Suppression Through Antigen Liver Expression Using mRNA-LNP Technology
- Kazunori Arai,
- Hanae Toyonaga,
- Lei Cheng and
- Hirotsugu Tanaka
Background: Messenger RNA-lipid nanoparticle (mRNA-LNP) is a cutting-edge nucleic acid intracellular delivery technology. Although the clinical use of the mRNA vaccine is being actively developed, the use of mRNA-LNP technology in common diseases suc...